Maria Twomey

Maria Twomey

Auto-generated profile, based on publicly available information

Maria Twomey

Department of Radiology, Cork University Hospital, Cork, Ireland

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in World Journal of Radiology
Verified
Journal Article
Open access
SPStephen P Power
Stephen P Power
FMFiachra Moloney
Fiachra Moloney
MTMaria Twomey
Maria Twomey
KJKarl James
Karl James
OOOwen J O’cOnnor
Owen J O’cOnnor
MMMichael M Maher
Michael M Maher
Computed tomography and patient risk: Facts, perceptions and uncertainties

10 January 2017 in British Journal of Cancer
Verified
Journal Article
Open access
LDLouise E Daly
Louise E Daly
DPDerek G Power
Derek G Power
ÁOÁine O'REilly
Áine O'REilly
PDPaul Donnellan
Paul Donnellan
SCSamantha J Cushen
Samantha J Cushen
ARAoife M Ryan
Aoife M Ryan
The BJC is owned by Cancer Research UK, a charity dedicated to understanding the causes, prevention and treatment of cancer and to making sure that the best new treatments reach patients in the clinic as quickly as possible. The journal reflects these aims. It was founded more than fifty years ago and, from the start, its far-sighted mission was to encourage communication of the very best cancer research from laboratories and clinics in all countries. The breadth of its coverage, its editorial independence and it consistent high standards, have made BJC one of the world's premier general cancer journals. Its increasing popularity is reflected by a steadily rising impact factor.

1 February 2018 in Chest
Verified
Journal Article
Open access
NRNicola J. Ronan
Nicola J. Ronan
GEGisli G. Einarsson
Gisli G. Einarsson
MTMaria Twomey
Maria Twomey
DMDenver Mooney
Denver Mooney
DMDavid Mullane
David Mullane
BPBarry J. Plant
Barry J. Plant
Ivacaftor produces significant clinical benefit in patients with cystic fibrosis (CF) with the G551D mutation. Prevalence of this mutation at the Cork CF Centre is 23%. This study assessed the impact of cystic fibrosis transmembrane conductance regulator modulation on multiple modalities of patient assessment. Thirty-three patients with the G551D mutation were assessed at baseline and prospectively every 3 months for 1 year after initiation of ivacaftor. Change in ultra-low-dose chest CT scans, blood inflammatory mediators, and the sputum microbiome were assessed. Significant improvements in FEV1, BMI, and sweat chloride levels were observed post-ivacaftor treatment. Improvement in ultra-low-dose CT imaging scores were observed after treatment, with significant mean reductions in total Bhalla score (P < .01), peribronchial thickening (P = .035), and extent of mucous plugging (P < .001). Reductions in circulating inflammatory markers, including interleukin (IL)-1β, IL-6, and IL-8 were demonstrated. There was a 30% reduction in the relative abundance of Pseudomonas species and an increase in the relative abundance of bacteria associated with more stable community structures. Posttreatment community richness increased significantly (P = .03). Early and sustained improvements on ultra-low-dose CT scores suggest it may be a useful method of evaluating treatment response. It paralleled improvement in symptoms, circulating inflammatory markers, and changes in the lung microbiota.

1 January 2018 in Journal of Gastric Cancer
Verified
Journal Article
Open access
PDF file
SOStephen O'Brien
Stephen O'Brien
MTMaria Twomey
Maria Twomey
FMFiachra Moloney
Fiachra Moloney
RKRichard G. Kavanagh
Richard G. Kavanagh
BCBrian Carey
Brian Carey
CÓCriostoir Ó'Súilleabháin
Criostoir Ó'Súilleabháin
O'Brien S, et al. J Gastric Cancer. 2018 Sep;18(3):242-252. https://doi.org/10.5230/jgc.2018.18.e25

16 December 2014 in Anatomical Sciences Education
Verified
Journal Article
Closed access
PDF file
KMKevin P. Murphy
Kevin P. Murphy
LCLee Crush
Lee Crush
EOEoin O'MAlley
Eoin O'MAlley
FDFergus E. Daly
Fergus E. Daly
MTMaria Twomey
Maria Twomey
OOOwen J. O'COnnor
Owen J. O'COnnor

11 December 2012 in Seminars in Interventional Radiology
Verified
Journal Article
Closed access
JSJennifer Sammon
Jennifer Sammon
MTMaria Twomey
Maria Twomey
LCLee Crush
Lee Crush
MMMichael M. Maher
Michael M. Maher
OOOwen J. O'Connor
Owen J. O'Connor
Percutaneous splenic biopsy and drainage are relatively safe and accurate procedures. The risk of major complication (1.3%) following percutaneous splenic biopsy does not exceed that of other solid intra-abdominal organ biopsies, and it has less morbidity and mortality than splenectomy. Both computed tomography and ultrasound can be used to provide image guidance for biopsy and drainage. The safety profile of fine-needle aspiration cytology is better than core needle biopsy, but core biopsy has superior diagnostic accuracy.